Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Of mice and men’s (and women’s) contraceptives

15.04.2005


Study of unique reproductive-cell protein in mice could lead to new contraceptives for women and men



Mice lacking a special protein found only in germ-line cells results in infertility in both males and females, according to a new study from researchers at the University of Pennsylvania School of Medicine. Norman Hecht, PhD, Professor of Human Reproduction in Penn’s Center for Research in Reproduction and Women’s Health, and colleagues say that these investigations point the way to a new type of contraceptive for both men and women. They report their findings in this week’s online edition of the Proceedings of the National Academy of Sciences.

"Not many proteins are expressed in both male and female germ lines that are specific only to the germ line," says Hecht. Germ line refers to the group of cells that give rise to either sperm or eggs in animals, as opposed to all other cell types, which are called somatic cells. "There are many proteins whose deletion will cause male infertility, and others for creating female infertility, but not many that will lead to both male and female infertility without affecting the somatic cells."


Animals deficient in the protein – called MSY2 – are infertile, but are otherwise healthy and completely normal. Male mice produce no functional sperm, and females show early loss of eggs and defects in ovulation.

The MSY2 protein is part of a family of proteins, called Y-box proteins, that are present in most organisms, ranging from bacteria to humans. In the nuclei of developing germ cells, MSY2 enhances synthesis of a select group of messenger RNA (mRNA) molecules and transports them from the nucleus into the cytoplasm. There, MSY2 proteins stabilize the mRNAs, which are used to make new proteins. Many of these proteins are critical for the production of normal sperm and also are unique to germ cells.

"When trying to develop a new contraceptive, it’s hard because we need to identify a target that’s specific to the germ cells," says Hecht. "Clearly, if we inactivate the function of a protein with a small inhibitory molecule, it can’t be a protein also active in such somatic tissues as brain, heart, liver, and so forth, only in the reproductive cells we want to target." Investigating germ cell molecules for contraception is also desirable because it frequently allows reversibility.

Hecht and colleagues have been proposing this scheme for the last several years, but how does the absence of the MSY2 protein result in male and female infertility? "We don’t know the complete mechanism yet, but it may be preventing the stabilization of specific messenger RNAs that need to be used at specific times as germ cells differentiate into mature sperm and eggs," explains Hecht. "An equally likely possibility is that the absence of MSY2 disrupts the timing of how specific mRNAs are used during germ cell differentiation. As cells become mature sperm, there’s a precise order of synthesis of many essential proteins needed to create functional gametes. We think the absence of the MSY2 protein causes problems in the timing of sperm or egg development. We’re working hard on understanding this mechanism."

A similar human equivalent of MSY2, Contrin, has been identified by the research group and their studies indicate it is also a germ cell-specific protein. Using MSY2 as a mouse model, Hecht and colleagues hope that Contrin can be developed as a new non-hormonal target for human contraception.

Karen Kreeger | EurekAlert!
Further information:
http://www.uphs.upenn.edu

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
21.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Nagoya physicists resolve long-standing mystery of structure-less transition

21.08.2017 | Materials Sciences

Chronic stress induces fatal organ dysfunctions via a new neural circuit

21.08.2017 | Health and Medicine

Scientists from the MSU studied new liquid-crystalline photochrom

21.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>